Answers are grounded in this paper and cite their sources.
Development and introduction of new biotechnological analogues (equivalents) of tissues and organs into clinical practice, such as human skin equivalents (SE), designed for temporal or permanent replacement of damaged or destroyed tissue, remains an urgent problem of regenerative medicine. Currently, full-thickness SE as well as separate skin layers, which include living cells of different types, are being created and investigated. Since the ideal skin substitutes have not been created, the efforts of researchers in many countries are aimed at solving this problem.
No takes yet. Share an insight, caveat, or question.
Meleshina et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: